These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 7717231)

  • 1. MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions.
    Moulton JS; Blebea JS; Dunco DM; Braley SE; Bisset GS; Emery KH
    AJR Am J Roentgenol; 1995 May; 164(5):1191-9. PubMed ID: 7717231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy.
    van Rijswijk CS; Geirnaerdt MJ; Hogendoorn PC; Taminiau AH; van Coevorden F; Zwinderman AH; Pope TL; Bloem JL
    Radiology; 2004 Nov; 233(2):493-502. PubMed ID: 15459325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions.
    Berquist TH; Ehman RL; King BF; Hodgman CG; Ilstrup DM
    AJR Am J Roentgenol; 1990 Dec; 155(6):1251-5. PubMed ID: 2122675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soft-tissue masses: diagnosis using MR imaging.
    Kransdorf MJ; Jelinek JS; Moser RP; Utz JA; Brower AC; Hudson TM; Berrey BH
    AJR Am J Roentgenol; 1989 Sep; 153(3):541-7. PubMed ID: 2763953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soft-tissue tumors of the foot: value of MR imaging for specific diagnosis.
    Wetzel LH; Levine E
    AJR Am J Roentgenol; 1990 Nov; 155(5):1025-30. PubMed ID: 2120930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric soft-tissue tumors and pseudo-tumors: MR imaging features with pathologic correlation: part 1. Imaging approach, pseudotumors, vascular lesions, and adipocytic tumors.
    Navarro OM; Laffan EE; Ngan BY
    Radiographics; 2009; 29(3):887-906. PubMed ID: 19448123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging differentiation of soft-tissue hemangiomas from malignant soft-tissue masses.
    Teo EL; Strouse PJ; Hernandez RJ
    AJR Am J Roentgenol; 2000 Jun; 174(6):1623-8. PubMed ID: 10845496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soft-tissue masses: use of a scoring system in differentiation of benign and malignant lesions.
    Mutlu H; Silit E; Pekkafali Z; Basekim CC; Ozturk E; Sildiroglu O; Kizilkaya E; Karsli AF
    Clin Imaging; 2006; 30(1):37-42. PubMed ID: 16377483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of MR findings in predicting the nature of the soft tissue lesions: benign, malignant or undetermined lesion?
    Soler R; Castro JM; Rodríguez E
    Comput Med Imaging Graph; 1996; 20(3):163-9. PubMed ID: 8930469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The identification of the criteria of malignancy and the tissue characterization of expansive processes in periskeletal soft tissues. The current role of magnetic resonance].
    Cappabianca S; De Luca AM; Iscaro FM; Sirignano C; Cantarella R; Del Vecchio W; Grassi R
    Radiol Med; 1999 Sep; 98(3):127-32. PubMed ID: 10575440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are signal intensity and homogeneity useful parameters for distinguishing between benign and malignant soft tissue masses on MR images? Objective evaluation by means of texture analysis.
    Mayerhoefer ME; Breitenseher M; Amann G; Dominkus M
    Magn Reson Imaging; 2008 Nov; 26(9):1316-22. PubMed ID: 18448302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones?
    Crim JR; Seeger LL; Yao L; Chandnani V; Eckardt JJ
    Radiology; 1992 Nov; 185(2):581-6. PubMed ID: 1410377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
    Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
    Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft tissue aspiration cytopathology.
    Wakely PE; Kneisl JS
    Cancer; 2000 Oct; 90(5):292-8. PubMed ID: 11038426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors.
    Doganay S; Altinok T; Alkan A; Kahraman B; Karakas HM
    Eur J Radiol; 2011 Aug; 79(2):e33-7. PubMed ID: 21376496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rethinking orbital imaging establishing guidelines for interpreting orbital imaging studies and evaluating their predictive value in patients with orbital tumors.
    Ben Simon GJ; Annunziata CC; Fink J; Villablanca P; McCann JD; Goldberg RA
    Ophthalmology; 2005 Dec; 112(12):2196-207. PubMed ID: 16325712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of 3T magnetic resonance dynamic contrast-enhanced and diffusion-weighted imaging in differential diagnosis of musculoskeletal tumors].
    Qi ZH; Li CF; Ma XX; Yang H; Jiang BD; Zhang K; Yu DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Apr; 34(2):138-45. PubMed ID: 22776599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of magnetic resonance imaging in the diagnosis of soft tissue lesions.
    Sharafuddin MJ; Sundaram M
    Crit Rev Diagn Imaging; 1994; 35(5):379-483. PubMed ID: 7832987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of computerized tomography and magnetic resonance in the assessment of benign and malignant pleural diseases].
    Falaschi F; Battolla L; Zampa V; Cioni R; Cambi L; Antonelli A; Bartolozzi C
    Radiol Med; 1996 Dec; 92(6):713-8. PubMed ID: 9122459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.